Lymphedema diagnosis by lower limb lymphangiography using MRI and gadolinium contrast medium

Lymphedema diagnosis by lower limb lymphangiography using MRI and gadolinium contrast medium - Lymphangiography with gadolinium

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034258

Enrollment

Registered

2018-10-01

Start date

2018-05-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Interventions

After administering gadolinium contrast agent to both lower limbs of lower limb lymphoedema patients, shooting at 3.0 T MRI and evaluate lymphatic vessel running. 8 ml of 0.5 mol / L water-soluble gad

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: An adult patient who is suspected of lymphedema and can maintain rest at the time of examination.

Exclusion criteria

Exclusion criteria: Patients who can not keep stability. Patients with a history of allergic reactions in gadolinium contrast agent, patients with findings of infection or inflammation at the time of examination. Patient with poor glycemic control.

Design outcomes

Primary

Measure	Time frame
Regarding the effectiveness, it is judged effective because the lymph duct can be recognized and recognized. Regarding safety, it is judged as safe that an adverse event does not occur at the 4th week after shooting.	—

Countries

Japan

Contacts

Public ContactHiroki Mitsuoka

Aichi medical univercity Vascular surgery

hiroki.m.i@aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026